genetix biotech asia private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 18 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 48 bids — GENETIX BIOTECH ASIA LIMITED appeared in 44 of them.
GENETIX BIOTECH ASIA PRIVATE LIMITED
GENETIX BIOTECH ASIA PRIVATE LIMITED
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
549
Contract Value
₹283.11 Cr
L1 Bids
227
Recent Win Rate
66.7%
Performance Analytics
Genetix Biotech Asia: Dominating Government Tenders with a 41% Win Rate
With a robust track record of 549 government tender participations, Genetix Biotech Asia Private Limited has strategically positioned itself within India's competitive public procurement arena. This detailed business analysis delves into their bidding efficacy, tender success trends, and competitive positioning in the biotech sector, offering key insights for stakeholders.
Executive Summary: Key Performance Metrics
Genetix Biotech Asia's financial performance demonstrates considerable strength in securing government contracts. Highlights include:
- A 41.3% tender win rate, significantly above the industry average.
- Securing 227 L1 positions, showcasing competitive pricing and strategic bidding.
- Participation in 18 high-value government contracts, indicating capability in managing significant public sector projects.
Financial Performance
Genetix Biotech Asia has displayed notable financial performance within the government tender landscape. Key financial metrics include: